Related Experiment Videos
[Histopathological changes produced in organs by platelet activating factor]
T Takiguchi1, X X Luo, H Ogata
1First Department of Anesthesiology, School of Medicine, Dokkyo University, Tochigi.
Masui. the Japanese Journal of Anesthesiology
|August 1, 1994
Summary
Platelet activating factor (PAF) causes acute organ damage, including intestinal villous necrosis. Chronic PAF exposure leads to lung hyaline thrombi and spleen enlargement in mice.
Area of Science:
- Pathology
- Immunology
- Toxicology
Context:
- Platelet activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
- Understanding PAF's organ-specific effects is crucial for developing targeted therapies.
- This study examines the pathological consequences of acute and chronic PAF administration in a murine model.
Purpose:
- To investigate the distinct pathological changes induced by acute and chronic exposure to platelet activating factor (PAF).
- To characterize organ-specific histopathological alterations following PAF administration.
- To identify key pathological markers associated with acute and chronic PAF toxicity.
Summary:
- Acute PAF injection (2.5 µg/kg IV) in C3H/HeN mice resulted in widespread congestion in lungs, liver, kidneys, and spleen, alongside small intestine villous necrosis.
- Chronic PAF administration (7.5 µg/kg IP for 7 days) led to lung hyaline thrombi, liver and kidney congestion, and splenomegaly with increased macrophages, but no intestinal necrosis.
- Distinct histopathological findings include acute intestinal villous necrosis and chronic lung hyaline thrombi and splenomegaly.
Impact:
- Provides critical insights into the dose- and duration-dependent organ toxicity of PAF.
- Highlights the differential pathological effects of PAF in acute versus chronic settings.
- Informs future research on PAF's role in inflammatory diseases and potential therapeutic interventions.